↓ Skip to main content

Efficacy of infliximab in refractory Behçet’s disease-associated and idiopathic posterior segment uveitis: a prospective, follow-up study of 50 patients

Overview of attention for article published in Biologics: Targets & Therapy, December 2011
Altmetric Badge

Citations

dimensions_citation
43 Dimensions

Readers on

mendeley
18 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Efficacy of infliximab in refractory Behçet’s disease-associated and idiopathic posterior segment uveitis: a prospective, follow-up study of 50 patients
Published in
Biologics: Targets & Therapy, December 2011
DOI 10.2147/btt.s27343
Pubmed ID
Authors

Fabrizio Cantini, Laura Niccoli, Carlotta Nannini, Olga Kaloudi, Emanuele Cassarà, Massimo Susini, Ivo Lenzetti

Abstract

To evaluate the long-term efficacy of infliximab in patients with refractory Behçet's disease (BD)-associated and idiopathic posterior uveitis (PU).

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Denmark 1 6%
Unknown 17 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 22%
Professor > Associate Professor 3 17%
Other 2 11%
Student > Ph. D. Student 2 11%
Student > Bachelor 1 6%
Other 4 22%
Unknown 2 11%
Readers by discipline Count As %
Medicine and Dentistry 14 78%
Immunology and Microbiology 1 6%
Pharmacology, Toxicology and Pharmaceutical Science 1 6%
Unknown 2 11%